Capital Investment Counsel, Inc Pfizer Inc Transaction History

Capital Investment Counsel, Inc

$805 Million
Q3 2025

A detailed history of Capital Investment Counsel, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Capital Investment Counsel, Inc holds 11,472 shares of PFE stock, worth $282,784. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,472

Previous 13,122 12.57%

Holding current value

$282,784

Previous $318,000 8.18%

% of portfolio

0.04%

Previous 0.04%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$23.29 - $25.88 $38,428 - $42,702	-1,650 Reduced 12.57%	11,472 $292,000
Q2 2025 Aug 08, 2025	SELL	$21.59 - $24.84 $28,088 - $32,316	-1,301 Reduced 9.02%	13,122 $318,000
Q1 2025 Apr 28, 2025	SELL	$25.01 - $27.13 $230,842 - $250,409	-9,230 Reduced 39.02%	14,423 $365,000
Q4 2024 Feb 03, 2025	SELL	$24.8 - $30.19 $166,060 - $202,152	-6,696 Reduced 22.06%	23,653 $627,000
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $39,694 - $44,981	-1,433 Reduced 4.51%	30,349 $878,000
Q2 2024 Jul 22, 2024	SELL	$25.26 - $29.6 $342,348 - $401,168	-13,553 Reduced 29.9%	31,782 $889,000
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $367,171 - $421,630	-14,182 Reduced 23.83%	45,335 $1.26 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $103,553 - $134,504	-3,963 Reduced 6.24%	59,517 $1.71 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $7,368 - $8,525	204 Added 0.32%	63,480 $2.33 Million
Q1 2023 Apr 27, 2023	SELL	$39.39 - $51.28 $55,146 - $71,792	-1,400 Reduced 2.16%	63,276 $2.58 Million
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $862,889 - $1.13 Million	20,668 Added 46.96%	64,676 $3.32 Million
Q3 2022 Oct 26, 2022	SELL	$43.76 - $53.42 $930,687 - $1.14 Million	-21,268 Reduced 32.58%	44,008 $1.93 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $16,797 - $19,916	-361 Reduced 0.55%	65,276 $3.42 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $64,050 - $79,366	-1,400 Reduced 2.09%	65,637 $3.4 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $308,040 - $456,618	-7,455 Reduced 10.01%	67,037 $3.96 Million
Q3 2021 Oct 25, 2021	BUY	$39.25 - $50.42 $13,070 - $16,789	333 Added 0.45%	74,492 $3.2 Million
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $1.67 Million - $1.9 Million	46,620 Added 169.29%	74,159 $2.9 Million
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $552,651 - $623,280	16,502 Added 149.52%	27,539 $998,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $562,362 - $715,093	-16,802 Reduced 60.35%	11,037 $406,000
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $533,463 - $625,874	16,802 Added 152.23%	27,839 $1.02 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $475,956 - $577,405	-15,802 Reduced 58.88%	11,037 $361,000
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $65,655 - $93,807	2,429 Added 9.95%	26,839 $876,000
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $1,086 - $1,232	-33 Reduced 0.14%	24,410 $956,000
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $18,779 - $24,351	-578 Reduced 2.31%	24,443 $878,000
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $34,502 - $38,738	933 Added 3.87%	25,021 $1.08 Million
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $18,750 - $20,600	500 Added 2.12%	24,088 $1.02 Million
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $18,234 - $22,117	-529 Reduced 2.19%	23,588 $1.04 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $59,495 - $63,428	-1,804 Reduced 6.96%	24,117 $875,000
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $2,648 - $3,072	83 Added 0.32%	25,921 $920,000
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $4,989 - $5,293	-150 Reduced 0.58%	25,838 $936,000
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $805,628 - $887,490	25,988	25,988 $928,000

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, Inc with notifications on news.

Account

Capital Investment Counsel, Inc Pfizer Inc Transaction History